| 标题 |
Cost-effectiveness comparison of dalpiciclib and abemaciclib combined with an aromatase inhibitor as first-line treatment for HR+/HER2− advanced breast cancer |
| 网址 | |
| DOI | |
| 其它 |
期刊:Expert Review of Pharmacoeconomics & Outcomes Research 作者:Juan Hong; Tujia Chen; Lihui Ouyang; Ning Du; Anna Li; et al 出版日期:2024 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)